Kazia Therapeutics
KZIA
6 hedge funds and large institutions have $580K invested in Kazia Therapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
19% more capital invested
Capital invested by funds: $486K → $580K (+$94K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$7.59K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.53K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$422 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$422 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$3.8K |
| 2 |
Citigroup
New York
|
-$422 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $338K | -$3.8K | -9 | -1% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $220K | +$422 | +1 | +0.2% |
|
|
3
Morgan Stanley
New York
| $16K | +$7.59K | +18 | +120% |
|
|
4
UBS Group
Zurich,
Switzerland
| $5K | +$2.53K | +6 | +150% |
|
5
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
6
Citigroup
New York
| – | -$422 | -1 | Closed |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$422 | +1 | New |
|
KZIA Hedge Fund Activity: Q1 2016 in Review
6 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2016, worth a combined $580K — up 19% from $486K a quarter earlier.
Fund positioning in KZIA was balanced in Q1 2016: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $7.59K. The largest seller was Renaissance Technologies, cutting an estimated $3.8K.
- 6 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $580K of Kazia Therapeutics stock for Q1 2016, up 19% quarter-over-quarter.
- 1 fund opened new Kazia Therapeutics positions in Q1 2016 and 1 closed out, a net change of 0 holders.
- The largest Kazia Therapeutics buyer in Q1 2016 was Morgan Stanley, an estimated $7.59K added.
- The largest Kazia Therapeutics seller in Q1 2016 was Renaissance Technologies, an estimated $3.8K sold.
Based on aggregated 13F filings for Q1 2016.